Laparoscopic Approach for Thermoablation Microwave in the Treatment of Hepatocellular Carcinoma: A Single Center Experience

2016 ◽  
Vol 26 (10) ◽  
pp. 808-811 ◽  
Author(s):  
Salvatore Gruttadauria ◽  
Duilio Pagano ◽  
Alessandro Tropea ◽  
Davide Cintorino ◽  
Luisa Castellana ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Laparoscopic Approach ◽  
Single Center ◽  
Single Center Experience

Liver transplantation for hepatocellular carcinoma: A single center experience

2004 ◽  
Vol 42 (05) ◽  
Author(s):  
V Stadlbauer ◽  
S Schaffellner ◽  
D Kniepeiss ◽  
E Jakoby ◽  
F Iberer ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Liver Transplantation ◽  
Single Center ◽  
Single Center Experience

scholarly journals Single-center experience on actual mid-term (≥5 years) and long-term (≥10 years) survival outcome in patients with hepatocellular carcinoma after curative hepatectomy

Medicine ◽  
2020 ◽  
Vol 99 (48) ◽  
pp. e23358
Author(s):  
Andrew K.Y. Fung ◽  
Nicole M.Y. Cheng ◽  
Charing C.N. Chong ◽  
Kit-Fai Lee ◽  
John Wong ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Survival Outcome ◽  
Single Center ◽  
Single Center Experience ◽  
Curative Hepatectomy

FRI-489-Downstaging by 90-yttrium radioembolization of unresectable locally advanced hepatocellular carcinoma: A single center experience

2019 ◽  
Vol 70 (1) ◽  
pp. e614
Author(s):  
Carolina Martelletti ◽  
Margherita Diotallevi ◽  
Amedeo Calvo ◽  
Nadia Russolillo ◽  
Alessandro Ferrero ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Locally Advanced ◽  
Advanced Hepatocellular Carcinoma ◽  
Single Center ◽  
Single Center Experience

Hepatocellular Carcinoma Occurrence/Recurrence after Direct-Acting Antivirals for Hepatitis C in Egyptian Cohort: Single-Center Experience

2019 ◽  
Vol 37 (6) ◽  
pp. 488-497
Author(s):  
Sameh A. Lashen ◽  
Mohammed M. Shamseya ◽  
Marwa A. Madkour
Keyword(s):  
Hepatocellular Carcinoma ◽  
Hepatitis C ◽  
De Novo ◽  
Independent Predictor ◽  
Alpha Fetoprotein ◽  
Direct Acting Antivirals ◽  
Single Center ◽  
Single Center Experience ◽  
Direct Acting ◽  
Hcc Recurrence

Background: Conflicting data have been published about the risk of hepatocellular carcinoma (HCC) following direct-acting antivirals (DAAs). We investigated the incidence of HCC occurrence/recurrence after DAAs therapy. Patients and Methods: Retrospectively, we analyzed data of 392 patients with F3–4 fibrosis and cirrhosis treated by DAAs during the period from August 2015 to May 2018. In HCC-experienced patients, HCC treatment modality, and the duration between HCC management and DAAs initiation were recorded. In all patients, pretreatment clinicolaboratory evaluation, and imaging before, during and after DAAs were done. Results: De novo HCC occurred in 7.6% of naïve patients, while recurrence appeared in 28% of patients with previous HCC. Pretreatment alpha-fetoprotein was an independent predictor of HCC occurrence, while the time between HCC ablation and the beginning of DAAs was the only predictor of HCC recurrence (p < 0.001). Half of the patients who started DAAs before 6 months had HCC recurrence, while patients who started DAAs at ≥6 months had no recurrence (p< 0.0001). Conclusions: Although HCC occurrence after DAAs was not high, recurrence was apparently high. Pretreatment alpha-fetoprotein is a predictor for de novo HCC. The time between HCC ablation and DAAs was the strongest predictor of recurrence.

Outcome of Liver Transplantation for Hepatocellular Carcinoma - a Single Center Experience

2012 ◽  
Vol 94 (10S) ◽  
pp. 632
Author(s):  
S. Iacob ◽  
R. Iacob ◽  
M. Grigorie ◽  
D. Hrehoret ◽  
V. Brasoveanu ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Liver Transplantation ◽  
Single Center ◽  
Single Center Experience
Sign in / Sign up

Export Citation Format

Share Document